Ortíz-Luna GF, Silvestri-Tomassoni JR, Aguilera-Pérez JR, Cardoza-López L, Velázquez-Valassi B, Llaca-Rodríguez V, Ahued-Ahued JR

Language: Spanish
References: 8
Page: 3-9
PDF size: 89.74 Kb.

ABSTRACT

Objective: Determine the BBM values and BMD in “health” patients, with osteopenia and osteoporosis as well as the association between biochemical bone markers and bone mineral density to determine Mexican patients during climacteric state in the Instituto Nacional de Perinatología. Methodology: A descriptive study of the biochemical bone markers (BBM) in patients (women) with osteopenia and osteoporosis. We determine the classification (normal, osteopenia and osteoporosis) with the values of the bone densitometry with the DEXA NorlandXR26 equipment. All the patients never had the background of have taken hormonal replacement therapy, also osteoporosis treatment. This study was transversal and observational. Results: Sixty patients (18.2%) had osteoporosis, 176 (53%) osteopenia and 91 (27.8%) normal. We found a significant association between deoxipiridinoline and bone densitometry measure. As lower we find the bone densitometry measure, higher we found the deoxipiridinoline value. Conclusions: As we compare deoxiporidinoline with each group of bone densitometry values, we found a significative difference between the three groups (normal, osteopenia and osteoporosis) with a p = 0.02.

REFERENCES

1. Clifford J, Hiller TA, Beck TJ, Rizzo JH, Pedula KL, Stone KL, Cauley JA. Osteoporosis and metabolic bone disease. Clin Lab Med 2000; (9): 489-502.

2. Toth CI, Dumon JC, DiRomana S, Kheddoumi N, Chebal H, Body JJ. Comparative study of the sensitivity of biochemical markers of bone formation in patients with osteopenia or osteoporosis. Osteoporos Int 2002; 13(Suppl 1): 57.

3. Yoshimura N, Nakatsuka K, Nishizawa Y, Sakata K, Hashimoto T. Biochemical markers and bone turn over and bone loss among men and women in a rural community in Japan, 1993-2000. The Taiji Study. Osteoporos Int 2002; 13(Suppl 1): 60.

4. Eastell R, Farlay D, Panczer G, Dupin- Roger I, Simi C, Buffet A. Bone markers. Biochemical and clinical perspectives. UK. Martin Dunitz LTD, 1a ed. 2001: 49-65.

5. Garnero, P, Eastell R, Delmas PD. High and low bone turnover classification of postmenopausal women by biochemical markers: influence of the day-to-day variability: the impact study. Osteoporos Int 2002; 13(Suppl 1): 52.

6. Panyakhamalerd K, Guthrie JR, Erbas B, Poon C, Ennerstein L, Ebeling PR. Biochemical, hormonal and genetic determinations of transmenopausal bone loss differ according to skeletal site. Osteoporos Int 2002; 13: 98 (P322MO).

7. Rivera-Espinoza G, Cordero Y, Ramos J, Marcano L. High remodeling turn over in Venezuelan osteoporotic patients. Osteoporos Int 2002; 13(Suppl 1): 58.

8. Balogh A, Bhattoa H, Bettembuk P. Osteoporosis risk profile and bone mineral density among postmenopausal women in a Hungarian region. JBMR 1999; 14(Suppl 1): 508-9.